CareLit · DOI-Nachweis · Pneumologie
Impact of Body Mass Index on Efficacy of Benralizumab in Patients with Severe, Uncontrolled Eosinophilic Asthma: Pooled Analysis of the SIROCCO and CALIMA Trials
DOI 10.1055/s-0039-1678228
Bibliografische Angaben
Nachweis in CareLit
Autor:innenF Trudo, I Hirsch, U Martin
ZeitschriftPneumologie
AusgabeS 01 S 01/2019
Jahrgang / SeitenJg. 73
Kernaussage aus der Literatur
Abstract-Vorschau
Impact of Body Mass Index on Efficacy of Benralizumab in Patients with Severe, Uncontrolled Eosinophilic Asthma: Pooled Analysis of the SIROCCO and CALIMA Trials
Zitieren
Zitierempfehlung
F Trudo, I Hirsch, U Martin (2019) Impact of Body Mass Index on Efficacy of Benralizumab in Patients with Severe, Uncontrolled Eosinophilic Asthma: Pooled Analysis of the SIROCCO and CALIMA Trials. Pneumologie, 73 (S 01 S 01). https://doi.org/10.1055/s-0039-1678228
Mit CareLit weiterarbeiten